Akouos AK-OTOF yields positive results in hearing restoration Phase 1/2 study
In a significant advancement for medical science and hearing loss treatment, Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), has unveiled encouraging initial clinical results from its Phase 1/2 AK-OTOF-101 study. This groundbreaking research, which demonstrated pharmacologic hearing restoration within 30 days of AK-OTOF administration in the first participant, marks […]